From Casetext: Smarter Legal Research

Hoffmann-La Roche Inc. v. Teva Pharms. USA, Inc.

United States Court of Appeals for the Federal Circuit
Sep 24, 2012
2012-1131 (Fed. Cir. Sep. 24, 2012)

Opinion

2012-1131

09-24-2012

HOFFMANN-LA ROCHE INC., Plaintiff-Appellant, v. TEVA PHARMACEUTICALS USA, INC. AND TEVA PHARMACEUTICAL INDUSTRIES LTD., Defendants-Appellees.


NOTE: This order is nonprecedential.

Appeal from the United States District Court for the District of New Jersey in case no. 09-CV-5283, Judge Esther Salas.

ON MOTION


ORDER

Hoffmann-LaRoche Inc. moves unopposed for a limited remand for the purpose of permitting the district court to enter an order granting a motion under Fed. R. Civ. P. 60(b) to amend the dismissal order to state that the appeal is dismissed "without prejudice." The district court issued an indicative order stating that it will amend the order as described if this court remands the appeal.

Upon consideration thereof,

IT IS ORDERED THAT:

The motion is granted and the remand is allowed for the limited purpose of allowing the district court to enter a ruling. This court otherwise retains jurisdiction over the appeal. The parties should promptly notify this court after the district court's ruling.

FOR THE COURT

___________

Jan Horbaly

Clerk
cc: Brian D. Coggio, Esq.

Jeffer Ali, Esq.
s25


Summaries of

Hoffmann-La Roche Inc. v. Teva Pharms. USA, Inc.

United States Court of Appeals for the Federal Circuit
Sep 24, 2012
2012-1131 (Fed. Cir. Sep. 24, 2012)
Case details for

Hoffmann-La Roche Inc. v. Teva Pharms. USA, Inc.

Case Details

Full title:HOFFMANN-LA ROCHE INC., Plaintiff-Appellant, v. TEVA PHARMACEUTICALS USA…

Court:United States Court of Appeals for the Federal Circuit

Date published: Sep 24, 2012

Citations

2012-1131 (Fed. Cir. Sep. 24, 2012)